Press release
Strong Growth Ahead: Liquid Biopsy For Cancer Diagnostics Market Size To Grow At Arecord 15.7% Cagr By 2029
Liquid Biopsy For Cancer Diagnostics
How Big Is the Liquid Biopsy For Cancer Diagnostics Market Size Expected to Be by 2034?
The market size for liquid biopsy used in cancer diagnostics has seen substantial expansion in the last few years. The market value, which stands at $9.23 billion in 2024, is projected to reach $10.78 billion in 2025, displaying a compound annual growth rate (CAGR) of 16.8%. This considerable growth during the historic timeframe can be linked to several factors, such as the enhancement in genomic research, heightened awareness about the advantages of liquid biopsy, the escalating occurrence of cancer, growing call for non-invasive cancer examinations, and the widespread introduction of precision medicine initiatives.
The market for liquid biopsy in cancer diagnostics is predicted to experience a rapid surge in the coming years. It is projected to escalate to $19.32 billion by 2029, with an impressive compound annual growth rate (CAGR) of 15.7%. The expansion throughout the projected period can be linked to the incorporation of liquid biopsy into regular cancer diagnostics, its use in early cancer detection, enlargement of cancer screening programs, increased emphasis on personalized medicine in oncology, and amplified funding for liquid biopsy research. Key trends during the forecast period encompass the rise of multi-omics liquid biopsy techniques, the use of artificial intelligence in liquid biopsy interpretation, broadening the use of liquid biopsy beyond oncology, evolving blood-based bio-markers for cancer, and tailoring liquid biopsy tests for specific cancer forms.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12205
What Are the Emerging Segments Within the Liquid Biopsy For Cancer Diagnostics Market?
The liquid biopsy for cancer diagnostics market covered in this report is segmented -
1) By Type: Product, Services
2) By Sample: Blood, Urine, Saliva
3) By Cancer: Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers
4) By End-User: Hospitals, Diagnostic Centers, Other End-Users
Subsegments:
1) By Product: Circulating Tumor Cells (CTCs) Detection Kits, Circulating Tumor DNA (ctDNA) Detection Kits, Exosome Isolation Kits, Sample Collection Devices
2) By Services: Testing Services, Analytical Services, Bioinformatics Services
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12205&type=smp
What Long-Term Drivers Are Shaping Liquid Biopsy For Cancer Diagnostics Market Trends?
The escalating rate of cancer occurrence is anticipated to drive the expansion of the liquid biopsy market for cancer diagnostics. Cancer is a broad group of diseases that can form in virtually any organ or tissue as unusual cells grow uncontrollably, go past their normal boundaries, and either spread to other organs or invade adjacent body parts. The increase in cancer cases necessitates diagnostic procedures such as early detection of cancer or tumor recurrence, patient risk evaluation, and treatment monitoring. This allows liquid biopsies to show the full extent of the disease, as tumor cells or their byproducts are released from all primary or metastatic tumor sites, supplying comprehensive and timely data on tumor cell adaptation, therapeutic targets, and the pathways of therapeutic resistance. For example, the National Cancer Institute, a US government agency, reported approximately 18.1 million cancer survivors in the US in May 2024. This number is likely to increase to 22.5 million by 2032, and by 2040, an expected 29.9 million new cancer cases will be diagnosed each year, with the number of cancer-related deaths anticipated to reach 15.3 million. Hence, the growing prevalence of cancer is propelling the liquid biopsy market for cancer diagnostics.
Who Are the Top Competitors in Key Liquid Biopsy For Cancer Diagnostics Market Segments?
Major companies operating in the liquid biopsy for cancer diagnostics market include F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation, Bio-Techne Corporation, ArcherDX Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Myriad Genetics Inc., Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., Biocartis Group NV, Biodesix Inc., MDx Health Inc., Sysmex Inostics Inc., Biocept Inc., Agena Bioscience Inc., Laboratory for Advanced Medicine (LAM) Inc., MiRXES Pte Ltd., Inivata Limited, Resolution Bioscience Inc., SAGA Diagnostics AB, NuProbe Inc., Personal Gemone Diagnostics Inc., Pathway Genomics Corporation, Angle PLC
What Liquid Biopsy For Cancer Diagnostics Market Trends Are Gaining Traction Across Different Segments?
A significant trend that is gaining traction in the liquid biopsy for cancer diagnostics market is the introduction of product innovations. Many leading businesses in the field are focusing on the development of novel products to bolster their market standing. For example, in June 2023, BostonGene, a biomedical software firm from the US, released new solutions for liquid biopsy that can pinpoint crucial genetic changes. The enlargement of test selection aims quicken the invention of new assays, analytical tools, and workflow processes to offer patients personalized healthcare. These solutions will utilize several techniques driven by artificial intelligence for molecular and immunological profiling to examine tumors, their microenvironments and the body's immune response. Besides, it aids immunotherapy treatments, provides intelligence on patients' immune-related illnesses, and monitors the advancement of the disease and the patient's reaction to the therapy.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report
Which Regions Are Becoming Hubs for Liquid Biopsy For Cancer Diagnostics Market Innovation?
North America was the largest region in the liquid biopsy for cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liquid biopsy for cancer diagnostics market report during the forecast period. The regions covered in the liquid biopsy for cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liquid Biopsy For Cancer Diagnostics Market?
2. What is the CAGR expected in the Liquid Biopsy For Cancer Diagnostics Market?
3. What Are the Key Innovations Transforming the Liquid Biopsy For Cancer Diagnostics Industry?
4. Which Region Is Leading the Liquid Biopsy For Cancer Diagnostics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Liquid Biopsy For Cancer Diagnostics Market Size To Grow At Arecord 15.7% Cagr By 2029 here
News-ID: 3998879 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
